A Phase I Study of HW201877 in Healthy Subjects

NCT07373457 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants
IBD (Inflammatory Bowel Disease)

Interventions

DRUG: HW201877 capsules
DRUG: Placebo

Sponsor

Wuhan Humanwell Innovative Drug Research and Development Center Limited Company